These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35067623)

  • 41. The Study on Safety in Hospitals in the Region of Madrid (ESHMAD) design: Screening and analysis of incidents and adverse events.
    Valencia-Martín JL; Martin-Delgado J; Pardo-Hernández A; Vicente-Guijarro J; Requena-Puche J; Aranaz Andrés JM;
    J Healthc Qual Res; 2021; 36(4):231-239. PubMed ID: 33967001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validity, reliability and feasibility of nutrition screening tools NRS-2002 and MST administered by trained medical doctors in routine practice.
    Cuong TQ; Banks M; Hannan-Jones M; Thi Ngoc Diep D; Gallegos D
    Hosp Pract (1995); 2019 Dec; 47(5):259-266. PubMed ID: 31791178
    [No Abstract]   [Full Text] [Related]  

  • 43. Performance of the Global Assessment of Pediatric Patient Safety (GAPPS) Tool.
    Landrigan CP; Stockwell D; Toomey SL; Loren S; Tracy M; Jang J; Quinn JA; Ashrafzadeh S; Wang M; Sharek PJ; Parry G; Schuster MA
    Pediatrics; 2016 Jun; 137(6):. PubMed ID: 27221286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. To what extent are adverse events found in patient records reported by patients and healthcare professionals via complaints, claims and incident reports?
    Christiaans-Dingelhoff I; Smits M; Zwaan L; Lubberding S; van der Wal G; Wagner C
    BMC Health Serv Res; 2011 Feb; 11():49. PubMed ID: 21356056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of adverse events in Sweden during 2013-2016: a cohort study describing the implementation of a national trigger tool.
    Nilsson L; Borgstedt-Risberg M; Soop M; Nylén U; Ålenius C; Rutberg H
    BMJ Open; 2018 Mar; 8(3):e020833. PubMed ID: 29602858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse Events Detection Through Global Trigger Tool Methodology: Results From a 5-Year Study in an Italian Hospital and Opportunities to Improve Interrater Reliability.
    Mortaro A; Moretti F; Pascu D; Tessari L; Tardivo S; Pancheri S; Marta G; Romano G; Mazzi M; Montresor P; Naessens JM
    J Patient Saf; 2021 Sep; 17(6):451-457. PubMed ID: 28598897
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design and reliability of a specific instrument to evaluate patient safety for patients with acute myocardial infarction treated in a predefined care track: a retrospective patient record review study in a single tertiary hospital in the Netherlands.
    Eindhoven DC; Borleffs CJ; Dietz MF; Schalij MJ; Brouwers C; de Bruijne MC
    BMJ Open; 2017 Mar; 7(3):e014360. PubMed ID: 28320797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detecting and reducing adverse events in an Australian rural base hospital emergency department using medical record screening and review.
    Wolff AM; Bourke J
    Emerg Med J; 2002 Jan; 19(1):35-40. PubMed ID: 11777869
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a trigger tool to identify adverse events and no-harm incidents that affect patients admitted to home healthcare.
    Lindblad M; Schildmeijer K; Nilsson L; Ekstedt M; Unbeck M
    BMJ Qual Saf; 2018 Jul; 27(7):502-511. PubMed ID: 28971884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improving patient safety by detecting obstetric care-related adverse events: application of a new screening guide.
    Aibar L; Rabanaque MJ; Mozas J; Puertas A; Aranaz JM; Aibar C
    Arch Gynecol Obstet; 2014 May; 289(5):945-52. PubMed ID: 24202544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Validation of triggers and development of a pediatric trigger tool to identify adverse events.
    Unbeck M; Lindemalm S; Nydert P; Ygge BM; Nylén U; Berglund C; Härenstam KP
    BMC Health Serv Res; 2014 Dec; 14():655. PubMed ID: 25527905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design of a medical record review study on the incidence and preventability of adverse events requiring a higher level of care in Belgian hospitals.
    Vlayen A; Marquet K; Schrooten W; Vleugels A; Hellings J; De Troy E; Weekers F; Claes N
    BMC Res Notes; 2012 Aug; 5():468. PubMed ID: 22931859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validity of cancer registry data for measuring the quality of breast cancer care.
    Malin JL; Kahn KL; Adams J; Kwan L; Laouri M; Ganz PA
    J Natl Cancer Inst; 2002 Jun; 94(11):835-44. PubMed ID: 12048271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validity of retrospective review of medical records as a means of identifying adverse events: comparison between medical records and accident reports.
    Kobayashi M; Ikeda S; Kitazawa N; Sakai H
    J Eval Clin Pract; 2008 Feb; 14(1):126-30. PubMed ID: 18211655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Limited external reproducibility restricts the use of medical record review for benchmarking.
    Klein DO; Rennenberg R; Gans R; Enting R; Koopmans R; Prins MH
    BMJ Open Qual; 2019; 8(2):e000564. PubMed ID: 31206063
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The incidence of adverse events in an Italian acute care hospital: findings of a two-stage method in a retrospective cohort study.
    Sommella L; de Waure C; Ferriero AM; Biasco A; Mainelli MT; Pinnarelli L; Ricciardi W; Damiani G
    BMC Health Serv Res; 2014 Aug; 14():358. PubMed ID: 25164708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of the validity and reliability of three systems of medical record screening for quality of care assessment.
    Camacho LA; Rubin HR
    Med Care; 1998 May; 36(5):748-51. PubMed ID: 9596065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of the incidence and preventability of adverse events in hospitals: an integrative review.
    Zanetti ACB; Gabriel CS; Dias BM; Bernardes A; Moura AA; Gabriel AB; Lima Júnior AJ
    Rev Gaucha Enferm; 2020; 41():e20190364. PubMed ID: 32667424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does increasing the size of bi-weekly samples of records influence results when using the Global Trigger Tool? An observational study of retrospective record reviews of two different sample sizes.
    Mevik K; Griffin FA; Hansen TE; Deilkås ET; Vonen B
    BMJ Open; 2016 Apr; 6(4):e010700. PubMed ID: 27113238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.